Concepedia

Joerg Kaufmann

JK

Statistics

Publications

5

Citations

635

H-Index

5

Active since

2003

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Klinikum Kassel

Universitätsklinik Marien Hospital Herne

University Medical Center Freiburg

University Hospital Ulm

Joerg Kaufmann is an author at Charité - Universitätsmedizin Berlin specializing in life sciences, pharmacology, and oncology.

Publications per year

2003–2020

5

Publications

5

Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus

Thomas Dörner, Joerg Kaufmann, William A. Wegener et al. · Arthritis Research & Therapy · 2006 · 307 citations · Full text

, , +16

Differential regulation of TGF-β signaling through Smad2, Smad3 and Smad4

Anny Kretschmer, Kristin Moepert, Sibylle Dames et al. · Oncogene · 2003 · 124 citations

, , +7

TRB3 is a PI 3-kinase dependent indicator for nutrient starvation

Rolf Schwarzer, Sybille Dames, Daniel Tondera et al. · Cellular Signalling · 2005 · 99 citations

, , +14

Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study

Beate Schultheis, Dirk Strumberg, Jan Kuhlmann et al. · Cancers · 2020 · 63 citations · Full text

, , +17

A phase Ib/IIa study of combination therapy with gemcitabine and Atu027 in patients with locally advanced or metastatic pancreatic adenocarcinoma.

Beate Schultheis, Dirk Strumberg, Jan Kuhlmann et al. · Journal of Clinical Oncology · 2016 · 42 citations

, , +15

1–5 of 5